U.S. FDA Approves Labeling Update of REXULTI (brexpiprazole) For Maintenance Treatment of Schizophrenia
September 23, 2016
Dr. Christoph U. Correll, Professor, Psychiatry, Hofstra Northwell School of Medicine, Medical Director, Recognition & Prevention Program (RAP), Zucker Hillside Hospital
Our representatives are available to schedule your appointment on weekdays from 8am to 8pm and weekends from 9am to 5pm. You may also leave a voicemail message after regular business hours, and we will return your call.